Sigma, AU000000SIG5

Sigma Healthcare stock: Founder sells major stake

Published on 11/13/2026 at 20:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sigma Healthcare stock faces potential extra supply after Chemist Warehouse co-founder Sam Gance sold a large stake. More block trades may follow.

Founder sale raises supply concerns

  • Chemist Warehouse co-founder Sam Gance sold 86.8 million Sigma shares.
  • Further block trades may follow as co-founder escrow restrictions expire.
Sigma, AU000000SIG5, Illustration mit AI erstellt.

Chemist Warehouse co-founder Sam Gance sold 86.8 million Sigma Healthcare shares on Friday, November 6, 2026, as billionaire co-founders' escrow restrictions began to expire. The sale was reported by the Australian Financial Review on November 10.

More shares may reach market

Gance sold the shares at AUD 2.88 each in a transaction worth about AUD 250 million, according to the report, which cited a substantial shareholder notice lodged with the Australian Securities Exchange. The sale is expected to be the first in a series of block trades involving shares held by Sigma's billionaire co-founders.

For investors, the potential sell-down adds a supply consideration alongside Sigma's operating performance. Further disposals could affect trading conditions while the remaining escrow restrictions expire.

Friday evening quotation

Sigma Healthcare stock traded at 1.78 euros on Lang & Schwarz at 20:30:51 CET on Friday, November 13, 2026.

Sigma Healthcare Limited

  • Company: Sigma Healthcare Limited
  • ISIN: AU000000SIG5
  • Ticker: SIG.AX
  • Home exchange: Australian Securities Exchange
  • Sector: Healthcare
  • Lang & Schwarz quote: 1.78 euros on November 13, 2026, at 20:30:51 CET

Australia's broader equity market can be followed through the S&P/ASX 200.

More news and analyses on Sigma Healthcare stock

Disclaimer...
en | AU000000SIG5 | SIGMA | boerse | 70506632 | bgmi